Georgina Wellstead
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Georgina Wellstead has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alexander James Fowler
Critical Care and Perioperative Medicine Research Group, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
4 shared publications - Dennis P. Orgill
Division of Plastic and Reconstructive Surgery, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA
4 shared publications - Riaz Ahmed Agha
Premier Science
3 shared publications - Katharine Whitehurst
University College London Medical School, Gower St, Bloomsbury, London, WC1E 6BT, UK
2 shared publications Mariana Devesa
University of East Anglia, Norwich, UK
2 shared publications- Peter McCulloch
Nuffield Department of Surgical Science, University of Oxford, Oxford, UK
2 shared publications
Latest Publications
- Open Access
- 30 January 2024
- Published by Wiley
Evaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
Objectives Admission of patients with necrotising otitis externa (NOE) has been rising steadily over the last five years and mortality and morbidity associated with the disease is high. Our objective is to assess the value of adjuvant hyperbaric oxygen therapy in patients with necrotising otitis externa. Design and setting A retrospective, observational, case-control study was conducted by examining patients’ records over a four-and-a-half-year period at two secondary care sites in the UK. The (Non-HBO) control group treated conventionally and the (HBO) group treated with additional adjuvant HBO in a multiple occupancy therapy chamber at the James Paget University Hospital. The primary outcome measure was death. Secondary outcomes measures were resolution of pain and recovery from otalgia, facial nerve palsy and other cranial nerve palsies. Results There were 10 patients in the HBO group and 20 in the non-HBO group; mean age was 82.3 years and 88.3 years respectively. The mortality rate was 30% in the HBO group compared to 55% in the non-HBO group. Patients tolerated HBO well, had greater resolution of pain (90% vs 64%) and resolution of facial nerve palsy (67% vs 31%) than the non-HBO group. Resolution of other cranial neuropathies was similar. Conclusion Our case series suggests that HBO is potentially a life-saving intervention. It also suggests that patients treated with HBO therapy for NOE appear to improve both in terms of pain and facial nerve palsies compared with conventional treatment and sets the precedent for a trial to formally compare the adjunctive intervention of HBO.
- 30 January 2024
- Published by Wiley
Open AccessEvaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
Objectives Admission of patients with necrotising otitis externa (NOE) has been rising steadily over the last five years and mortality and morbidity associated with the disease is high. Our objective is to assess the value of adjuvant hyperbaric oxygen therapy in patients with necrotising otitis externa. Design and setting A retrospective, observational, case-control study was conducted by examining patients’ records over a four-and-a-half-year period at two secondary care sites in the UK. The (Non-HBO) control group treated conventionally and the (HBO) group treated with additional adjuvant HBO in a multiple occupancy therapy chamber at the James Paget University Hospital. The primary outcome measure was death. Secondary outcomes measures were resolution of pain and recovery from otalgia, facial nerve palsy and other cranial nerve palsies. Results There were 10 patients in the HBO group and 20 in the non-HBO group; mean age was 82.3 years and 88.3 years respectively. The mortality rate was 30% in the HBO group compared to 55% in the non-HBO group. Patients tolerated HBO well, had greater resolution of pain (90% vs 64%) and resolution of facial nerve palsy (67% vs 31%) than the non-HBO group. Resolution of other cranial neuropathies was similar. Conclusion Our case series suggests that HBO is potentially a life-saving intervention. It also suggests that patients treated with HBO therapy for NOE appear to improve both in terms of pain and facial nerve palsies compared with conventional treatment and sets the precedent for a trial to formally compare the adjunctive intervention of HBO.
- 27 September 2019
- Published by Wiley in Clinical Otolaryngology
- Vol. 44 (6) , 1236-1238
The use of Floseal® in middle ear bleeding (Correspondence: Technical notes)
- 27 September 2019
- Published by Wiley in Clinical Otolaryngology
- Vol. 44 (6) , 1236-1238
The use of Floseal® in middle ear bleeding (Correspondence: Technical notes)
- 1 August 2017
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 44, 215-222
The use of study registration and protocols in plastic surgery research: A systematic review
In 2013, the Declaration of Helsinki changed to mandate that all research studies involving human subjects, rather than just clinical trials alone, must have a protocol registered in a publicly accessible database prior to the enrolment of the first patient. The objective of this work was to assess the number of research studies involving human participants published in leading journals of plastic surgery that had either published a protocol or registered a protocol with a publicly accessible database. This systematic review examined all research articles involving human participants published in Plastic and Reconstructive Surgery, The Journal of Plastic Reconstructive and Aesthetic Surgery and The Annals of Plastic Surgery from 1st April 2014-31st March 2015. The primary outcome measure was whether each study had either published or registered a protocol with any mainstream registry database. ClinicalTrials.gov, the International Standard Randomized Control Trial Number (ISRCTN) registry, the WHO (World Health Organisation) International Clinical Trials Registry Platform, The Cochrane Collaboration, the Research Registry, PROSPERO and PubMed were all reviewed. Of 595 included articles, the most common study designs were case series (n = 185, 31.1%). There were 24 randomized controlled trials (RCTs, 4.0%). A total of 24 studies had a protocol registered (4.0%). The most common database to register a protocol was with ClinicalTrials.gov (n = 17). The study design that most commonly had a registered protocol was the RCT (n = 8 of 24, 33.3% of RCTs). Three studies published a protocol in a journal (0.6%). Publication or registration of protocols for recent studies involving human participants in major plastic surgery journals is low. There is considerable scope to improve this and guidance is provided.
- 1 August 2017
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 44, 215-222
The use of study registration and protocols in plastic surgery research: A systematic review
In 2013, the Declaration of Helsinki changed to mandate that all research studies involving human subjects, rather than just clinical trials alone, must have a protocol registered in a publicly accessible database prior to the enrolment of the first patient. The objective of this work was to assess the number of research studies involving human participants published in leading journals of plastic surgery that had either published a protocol or registered a protocol with a publicly accessible database. This systematic review examined all research articles involving human participants published in Plastic and Reconstructive Surgery, The Journal of Plastic Reconstructive and Aesthetic Surgery and The Annals of Plastic Surgery from 1st April 2014-31st March 2015. The primary outcome measure was whether each study had either published or registered a protocol with any mainstream registry database. ClinicalTrials.gov, the International Standard Randomized Control Trial Number (ISRCTN) registry, the WHO (World Health Organisation) International Clinical Trials Registry Platform, The Cochrane Collaboration, the Research Registry, PROSPERO and PubMed were all reviewed. Of 595 included articles, the most common study designs were case series (n = 185, 31.1%). There were 24 randomized controlled trials (RCTs, 4.0%). A total of 24 studies had a protocol registered (4.0%). The most common database to register a protocol was with ClinicalTrials.gov (n = 17). The study design that most commonly had a registered protocol was the RCT (n = 8 of 24, 33.3% of RCTs). Three studies published a protocol in a journal (0.6%). Publication or registration of protocols for recent studies involving human participants in major plastic surgery journals is low. There is considerable scope to improve this and guidance is provided.
- 1 November 2016
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 77 (5) , 506-512
The Need for Core Outcome Reporting in Autologous Fat Grafting for Breast Reconstruction
There is growing interest in autologous fat grafting (AFG) for breast reconstruction. This systematic review examines the range of outcomes used across studies of AFG, their definitions and whether there is a need for a core outcome set to aid reporting.Following the protocol of our systematic review, a search of 20 databases (1986 to March 2014) returned 35 studies which met the inclusion criteria. These were assessed independently by two authors. Disagreements were resolved by consensus.Of the 35 studies, 27 (77%) were case series, 5 (14.3%) were cohort studies, and 3 (8.6%) were case reports. A total of 51 different outcomes were reported. These studies each reported a median of five separate outcomes (range, 2-14), of which a median of 3 outcomes were defined (range, 0-14). A median of 2 outcomes per paper were prespecified in the study methods (range, 0-12) and a median of only 2 outcomes per paper (range, 0-12) were both defined and prespecified. The most commonly reported outcome in studies of AFG was that of "operative details," reported by 26 studies, and eight different outcome definitions were used. "Cancer recurrence" was reported by 20 studies, with the use of 10 different outcome definitions. Overall, there was a poor proportion of defined and prespecified outcomes that employed a wide range of different outcome definitions. In addition only 14/35 studies stated the number of patients lost to follow-up.There is a need for a core outcomes set for AFG to the breast to minimise outcome and reporting bias and aid evidence synthesis. Our future research will focus in this direction, titled VOGUE or Valid Outcomes for the Grafting of AUtologous Fat to the BrEast study. We invite all those interested to get in touch with the lead author.
- 1 November 2016
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 77 (5) , 506-512
The Need for Core Outcome Reporting in Autologous Fat Grafting for Breast Reconstruction
There is growing interest in autologous fat grafting (AFG) for breast reconstruction. This systematic review examines the range of outcomes used across studies of AFG, their definitions and whether there is a need for a core outcome set to aid reporting.Following the protocol of our systematic review, a search of 20 databases (1986 to March 2014) returned 35 studies which met the inclusion criteria. These were assessed independently by two authors. Disagreements were resolved by consensus.Of the 35 studies, 27 (77%) were case series, 5 (14.3%) were cohort studies, and 3 (8.6%) were case reports. A total of 51 different outcomes were reported. These studies each reported a median of five separate outcomes (range, 2-14), of which a median of 3 outcomes were defined (range, 0-14). A median of 2 outcomes per paper were prespecified in the study methods (range, 0-12) and a median of only 2 outcomes per paper (range, 0-12) were both defined and prespecified. The most commonly reported outcome in studies of AFG was that of "operative details," reported by 26 studies, and eight different outcome definitions were used. "Cancer recurrence" was reported by 20 studies, with the use of 10 different outcome definitions. Overall, there was a poor proportion of defined and prespecified outcomes that employed a wide range of different outcome definitions. In addition only 14/35 studies stated the number of patients lost to follow-up.There is a need for a core outcomes set for AFG to the breast to minimise outcome and reporting bias and aid evidence synthesis. Our future research will focus in this direction, titled VOGUE or Valid Outcomes for the Grafting of AUtologous Fat to the BrEast study. We invite all those interested to get in touch with the lead author.
- 1 October 2016
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 44 (10) , 1522-1530
An assessment of the compliance of systematic review articles published in craniofacial surgery with the PRISMA statement guidelines: A systematic review
- 1 October 2016
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 44 (10) , 1522-1530
An assessment of the compliance of systematic review articles published in craniofacial surgery with the PRISMA statement guidelines: A systematic review
- 18 July 2016
- Published by Springer Nature in European Journal of Plastic Surgery
- Vol. 39 (5) , 365-370
Levels of evidence in plastic surgery—bibliometric trends and comparison with five other surgical specialties
- 18 July 2016
- Published by Springer Nature in European Journal of Plastic Surgery
- Vol. 39 (5) , 365-370
Levels of evidence in plastic surgery—bibliometric trends and comparison with five other surgical specialties
- 1 October 2015
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 221 (4) , S115-S116
Levels of Evidence in Plastic Surgery: Trends and Comparison with 5 Other Surgical Specialties
- 1 October 2015
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 221 (4) , S115-S116
Levels of Evidence in Plastic Surgery: Trends and Comparison with 5 Other Surgical Specialties